| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 22 | 2025 | 197 | 5.990 |
Why?
|
| Gynecologic Surgical Procedures | 19 | 2024 | 184 | 3.460 |
Why?
|
| Nursing Informatics | 4 | 2017 | 4 | 1.970 |
Why?
|
| Suburethral Slings | 8 | 2024 | 87 | 1.780 |
Why?
|
| Urinary Incontinence | 5 | 2024 | 225 | 1.710 |
Why?
|
| Vagina | 14 | 2024 | 186 | 1.700 |
Why?
|
| Urinary Incontinence, Stress | 9 | 2024 | 212 | 1.610 |
Why?
|
| Hysterectomy | 7 | 2025 | 174 | 1.380 |
Why?
|
| Pelvic Floor Disorders | 5 | 2023 | 62 | 1.210 |
Why?
|
| Nurse Administrators | 2 | 2017 | 3 | 1.030 |
Why?
|
| Patient Satisfaction | 9 | 2023 | 511 | 1.000 |
Why?
|
| Professional Competence | 2 | 2017 | 65 | 0.990 |
Why?
|
| Medical Informatics | 2 | 2017 | 51 | 0.910 |
Why?
|
| Gynecology | 3 | 2023 | 135 | 0.890 |
Why?
|
| Female | 69 | 2025 | 51570 | 0.880 |
Why?
|
| Obstetrics | 2 | 2023 | 125 | 0.820 |
Why?
|
| Electronic Health Records | 3 | 2023 | 442 | 0.820 |
Why?
|
| Blood Transfusion | 2 | 2025 | 180 | 0.820 |
Why?
|
| Clinical Decision-Making | 2 | 2024 | 305 | 0.730 |
Why?
|
| Pelvic Floor | 4 | 2022 | 88 | 0.700 |
Why?
|
| Patient Participation | 3 | 2021 | 246 | 0.690 |
Why?
|
| Pain Measurement | 3 | 2021 | 401 | 0.670 |
Why?
|
| Muscle, Striated | 1 | 2021 | 6 | 0.670 |
Why?
|
| Humans | 72 | 2025 | 98135 | 0.660 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 132 | 0.600 |
Why?
|
| Uterine Prolapse | 4 | 2024 | 82 | 0.590 |
Why?
|
| Laparoscopy | 7 | 2025 | 792 | 0.570 |
Why?
|
| Quality of Life | 6 | 2022 | 1895 | 0.560 |
Why?
|
| Robotics | 2 | 2012 | 272 | 0.540 |
Why?
|
| Postoperative Complications | 12 | 2024 | 2680 | 0.540 |
Why?
|
| Sacrum | 3 | 2024 | 82 | 0.530 |
Why?
|
| Aged | 30 | 2025 | 21760 | 0.520 |
Why?
|
| Middle Aged | 36 | 2025 | 29442 | 0.510 |
Why?
|
| Societies, Nursing | 1 | 2016 | 2 | 0.500 |
Why?
|
| Pregnancy Complications | 1 | 2020 | 365 | 0.500 |
Why?
|
| Urogenital Surgical Procedures | 2 | 2014 | 10 | 0.500 |
Why?
|
| Pelvis | 2 | 2021 | 106 | 0.460 |
Why?
|
| Retrospective Studies | 23 | 2025 | 10962 | 0.460 |
Why?
|
| Psychometrics | 1 | 2017 | 357 | 0.450 |
Why?
|
| Educational Measurement | 1 | 2017 | 241 | 0.450 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 199 | 0.440 |
Why?
|
| Urologic Surgical Procedures | 3 | 2021 | 154 | 0.440 |
Why?
|
| Skin Diseases | 1 | 2017 | 176 | 0.440 |
Why?
|
| Vaginal Discharge | 1 | 2014 | 2 | 0.430 |
Why?
|
| Health Policy | 1 | 2016 | 216 | 0.430 |
Why?
|
| Pessaries | 1 | 2014 | 11 | 0.420 |
Why?
|
| Treatment Outcome | 16 | 2024 | 9713 | 0.420 |
Why?
|
| Internship and Residency | 1 | 2023 | 1123 | 0.410 |
Why?
|
| Robotic Surgical Procedures | 4 | 2024 | 411 | 0.410 |
Why?
|
| Urinary Incontinence, Urge | 3 | 2024 | 54 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 601 | 0.390 |
Why?
|
| Constipation | 2 | 2024 | 68 | 0.390 |
Why?
|
| Postoperative Care | 3 | 2021 | 236 | 0.380 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 3022 | 0.380 |
Why?
|
| Recovery of Function | 3 | 2021 | 370 | 0.370 |
Why?
|
| Urinary Tract | 2 | 2023 | 34 | 0.360 |
Why?
|
| Anal Canal | 3 | 2021 | 94 | 0.360 |
Why?
|
| Defecation | 1 | 2012 | 26 | 0.360 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2025 | 309 | 0.350 |
Why?
|
| Malformations of Cortical Development | 3 | 2016 | 46 | 0.350 |
Why?
|
| Adult | 23 | 2025 | 29564 | 0.350 |
Why?
|
| Prospective Studies | 7 | 2022 | 4825 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 1012 | 0.330 |
Why?
|
| Abscess | 1 | 2011 | 94 | 0.330 |
Why?
|
| Quality Improvement | 5 | 2022 | 520 | 0.330 |
Why?
|
| Low Back Pain | 1 | 2011 | 62 | 0.330 |
Why?
|
| Clinical Competence | 2 | 2022 | 865 | 0.320 |
Why?
|
| Lower Urinary Tract Symptoms | 2 | 2023 | 89 | 0.310 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2021 | 56 | 0.310 |
Why?
|
| Reoperation | 3 | 2022 | 726 | 0.300 |
Why?
|
| Sexuality | 1 | 2010 | 40 | 0.300 |
Why?
|
| Motor Activity | 1 | 2012 | 331 | 0.300 |
Why?
|
| Hypogastric Plexus | 1 | 2009 | 3 | 0.290 |
Why?
|
| Adnexa Uteri | 1 | 2009 | 11 | 0.290 |
Why?
|
| Ligaments | 1 | 2009 | 33 | 0.290 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2009 | 22 | 0.290 |
Why?
|
| Lakes | 2 | 2017 | 8 | 0.270 |
Why?
|
| Rectal Prolapse | 1 | 2007 | 10 | 0.260 |
Why?
|
| Narcotics | 2 | 2021 | 74 | 0.250 |
Why?
|
| Surgical Mesh | 2 | 2022 | 126 | 0.250 |
Why?
|
| Mosaicism | 2 | 2016 | 74 | 0.240 |
Why?
|
| Referral and Consultation | 2 | 2021 | 418 | 0.240 |
Why?
|
| Delivery, Obstetric | 3 | 2021 | 120 | 0.230 |
Why?
|
| Risk Factors | 5 | 2025 | 6232 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 2037 | 0.220 |
Why?
|
| Postoperative Period | 3 | 2021 | 322 | 0.210 |
Why?
|
| Risk Reduction Behavior | 1 | 2024 | 102 | 0.210 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 7387 | 0.210 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 12 | 0.200 |
Why?
|
| Life Style | 1 | 2024 | 193 | 0.200 |
Why?
|
| Congenital Abnormalities | 1 | 2023 | 69 | 0.190 |
Why?
|
| Pregnancy | 5 | 2021 | 3244 | 0.190 |
Why?
|
| Women's Health | 1 | 2023 | 119 | 0.190 |
Why?
|
| Emotions | 2 | 2023 | 387 | 0.180 |
Why?
|
| Time-to-Treatment | 2 | 2021 | 157 | 0.180 |
Why?
|
| Urethra | 2 | 2021 | 108 | 0.170 |
Why?
|
| Fecal Incontinence | 1 | 2021 | 62 | 0.170 |
Why?
|
| Exercise | 2 | 2024 | 380 | 0.170 |
Why?
|
| Water Quality | 2 | 2017 | 5 | 0.170 |
Why?
|
| Convalescence | 1 | 2021 | 10 | 0.170 |
Why?
|
| Contraceptive Agents | 1 | 2021 | 28 | 0.170 |
Why?
|
| Obstetric Labor Complications | 1 | 2021 | 33 | 0.160 |
Why?
|
| Neuromuscular Agents | 1 | 2021 | 27 | 0.160 |
Why?
|
| Lacerations | 1 | 2021 | 29 | 0.160 |
Why?
|
| Goals | 1 | 2021 | 69 | 0.160 |
Why?
|
| Patient Selection | 1 | 2024 | 725 | 0.160 |
Why?
|
| Supine Position | 1 | 2020 | 34 | 0.160 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 52 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 63 | 0.160 |
Why?
|
| Uterus | 1 | 2022 | 232 | 0.150 |
Why?
|
| Primary Health Care | 1 | 2024 | 395 | 0.150 |
Why?
|
| Organ Size | 1 | 2021 | 370 | 0.150 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2019 | 5 | 0.150 |
Why?
|
| Linear Models | 1 | 2021 | 424 | 0.150 |
Why?
|
| Abdomen | 1 | 2020 | 120 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2020 | 70 | 0.150 |
Why?
|
| Pressure | 1 | 2020 | 173 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2022 | 351 | 0.150 |
Why?
|
| Circumcision, Female | 1 | 2019 | 4 | 0.150 |
Why?
|
| Telemedicine | 1 | 2023 | 250 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 134 | 0.140 |
Why?
|
| Urination Disorders | 1 | 2019 | 52 | 0.140 |
Why?
|
| Decision Making | 1 | 2024 | 686 | 0.140 |
Why?
|
| Mutation | 5 | 2018 | 4392 | 0.140 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2018 | 15 | 0.140 |
Why?
|
| Lissencephaly | 1 | 2018 | 24 | 0.140 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2018 | 37 | 0.140 |
Why?
|
| Self Care | 1 | 2019 | 189 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 285 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2018 | 68 | 0.130 |
Why?
|
| United States | 5 | 2019 | 8193 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 224 | 0.130 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2018 | 76 | 0.130 |
Why?
|
| Chlorophyll | 1 | 2017 | 45 | 0.130 |
Why?
|
| Cerebellum | 1 | 2019 | 253 | 0.130 |
Why?
|
| Logistic Models | 1 | 2021 | 1275 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2025 | 2585 | 0.130 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 93 | 0.130 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2017 | 40 | 0.130 |
Why?
|
| Directive Counseling | 1 | 2017 | 34 | 0.120 |
Why?
|
| Surgeons | 1 | 2022 | 325 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 250 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2024 | 658 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2020 | 1090 | 0.120 |
Why?
|
| Recurrence | 1 | 2020 | 1254 | 0.120 |
Why?
|
| Patient Handoff | 1 | 2018 | 100 | 0.120 |
Why?
|
| Climate Change | 1 | 2017 | 80 | 0.120 |
Why?
|
| Sutures | 2 | 2024 | 59 | 0.120 |
Why?
|
| Megalencephaly | 1 | 2016 | 21 | 0.120 |
Why?
|
| Vascular Malformations | 1 | 2016 | 19 | 0.120 |
Why?
|
| Delphi Technique | 1 | 2017 | 181 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 19 | 0.120 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2016 | 12 | 0.120 |
Why?
|
| Lipomatosis | 1 | 2016 | 9 | 0.120 |
Why?
|
| Male | 11 | 2023 | 47109 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2020 | 289 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 83 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 155 | 0.120 |
Why?
|
| Eye Diseases | 1 | 2016 | 59 | 0.110 |
Why?
|
| Microbiota | 1 | 2021 | 468 | 0.110 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 29 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2018 | 340 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 342 | 0.110 |
Why?
|
| Database Management Systems | 1 | 2015 | 44 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 338 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 233 | 0.110 |
Why?
|
| Ecology | 1 | 2015 | 84 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 220 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 1103 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2017 | 320 | 0.100 |
Why?
|
| Intellectual Disability | 1 | 2015 | 202 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 235 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 916 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 2014 | 90 | 0.100 |
Why?
|
| Analgesia | 1 | 2014 | 65 | 0.100 |
Why?
|
| Communication | 1 | 2017 | 456 | 0.100 |
Why?
|
| Incidence | 4 | 2019 | 1777 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2015 | 387 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2017 | 520 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2021 | 3213 | 0.090 |
Why?
|
| Urinary Retention | 2 | 2024 | 44 | 0.090 |
Why?
|
| Rheumatology | 1 | 2013 | 47 | 0.090 |
Why?
|
| Pain Management | 1 | 2014 | 194 | 0.090 |
Why?
|
| Rheumatic Diseases | 1 | 2013 | 37 | 0.090 |
Why?
|
| Rectocele | 1 | 2012 | 7 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2014 | 418 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2021 | 1783 | 0.080 |
Why?
|
| Osteomyelitis | 1 | 2011 | 57 | 0.080 |
Why?
|
| Genetic Association Studies | 3 | 2018 | 310 | 0.080 |
Why?
|
| Operative Time | 2 | 2024 | 174 | 0.080 |
Why?
|
| Drug-Eluting Stents | 1 | 2010 | 24 | 0.080 |
Why?
|
| Blood Loss, Surgical | 2 | 2024 | 139 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 66 | 0.080 |
Why?
|
| Genital Diseases, Female | 1 | 2010 | 23 | 0.080 |
Why?
|
| Vena Cava, Inferior | 1 | 2011 | 140 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 55 | 0.080 |
Why?
|
| Postpartum Period | 2 | 2021 | 169 | 0.080 |
Why?
|
| Flatulence | 1 | 2009 | 2 | 0.080 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2009 | 38 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 2009 | 20 | 0.070 |
Why?
|
| Enzymes | 1 | 2009 | 47 | 0.070 |
Why?
|
| Sphingosine | 1 | 2009 | 73 | 0.070 |
Why?
|
| Lysophospholipids | 1 | 2009 | 67 | 0.070 |
Why?
|
| Cadaver | 1 | 2009 | 200 | 0.070 |
Why?
|
| Thrombosis | 1 | 2011 | 318 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 244 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 985 | 0.070 |
Why?
|
| Urology | 1 | 2010 | 144 | 0.070 |
Why?
|
| Young Adult | 5 | 2023 | 7511 | 0.070 |
Why?
|
| Prevalence | 2 | 2024 | 1383 | 0.060 |
Why?
|
| Brain | 1 | 2018 | 2448 | 0.060 |
Why?
|
| Tertiary Care Centers | 2 | 2018 | 131 | 0.060 |
Why?
|
| Urinary Bladder | 1 | 2009 | 262 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 396 | 0.060 |
Why?
|
| Adolescent | 5 | 2023 | 10097 | 0.060 |
Why?
|
| Time Factors | 3 | 2024 | 5576 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 194 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2787 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 548 | 0.060 |
Why?
|
| Infant | 3 | 2016 | 3332 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2016 | 4006 | 0.050 |
Why?
|
| Needles | 1 | 2024 | 43 | 0.050 |
Why?
|
| Mullerian Ducts | 1 | 2023 | 21 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2024 | 140 | 0.050 |
Why?
|
| Child | 3 | 2023 | 7699 | 0.050 |
Why?
|
| Weight Loss | 1 | 2024 | 245 | 0.050 |
Why?
|
| Equipment Design | 1 | 2024 | 427 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 211 | 0.050 |
Why?
|
| Office Visits | 1 | 2023 | 49 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 2023 | 60 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 593 | 0.040 |
Why?
|
| Grooming | 1 | 2021 | 17 | 0.040 |
Why?
|
| Urodynamics | 1 | 2022 | 130 | 0.040 |
Why?
|
| Sexism | 1 | 2022 | 64 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2022 | 96 | 0.040 |
Why?
|
| Administration, Intravesical | 1 | 2021 | 40 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2021 | 346 | 0.040 |
Why?
|
| Fertility | 1 | 2021 | 120 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 59 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 270 | 0.040 |
Why?
|
| Quality Control | 1 | 2020 | 130 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 68 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 103 | 0.040 |
Why?
|
| Obesity | 1 | 2007 | 1061 | 0.040 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2019 | 15 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2018 | 850 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2022 | 720 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3618 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 4026 | 0.040 |
Why?
|
| Nocturia | 1 | 2019 | 23 | 0.040 |
Why?
|
| Animals | 4 | 2023 | 28902 | 0.040 |
Why?
|
| Orgasm | 1 | 2018 | 9 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 78 | 0.030 |
Why?
|
| Mass Screening | 1 | 2024 | 745 | 0.030 |
Why?
|
| Wound Healing | 1 | 2021 | 384 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2009 | 3621 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 336 | 0.030 |
Why?
|
| Eutrophication | 1 | 2017 | 5 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 37 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 119 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.030 |
Why?
|
| Nitrogen | 1 | 2017 | 74 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 2017 | 71 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1751 | 0.030 |
Why?
|
| Food | 1 | 2017 | 93 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2017 | 92 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 4072 | 0.030 |
Why?
|
| Checklist | 1 | 2017 | 78 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2018 | 144 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1815 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 49 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 220 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 290 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 214 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 106 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 246 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 196 | 0.030 |
Why?
|
| Eye | 1 | 2016 | 113 | 0.030 |
Why?
|
| Exome | 1 | 2016 | 145 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 550 | 0.030 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2016 | 104 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 235 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 663 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 211 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2016 | 302 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 370 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 512 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1109 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 1967 | 0.020 |
Why?
|
| Seizures | 1 | 2016 | 324 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 911 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2013 | 123 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 583 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 568 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 2013 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2855 | 0.020 |
Why?
|
| Hirudins | 1 | 2010 | 7 | 0.020 |
Why?
|
| Antithrombins | 1 | 2010 | 20 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2888 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 2638 | 0.020 |
Why?
|
| Lyases | 1 | 2009 | 11 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 64 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2009 | 71 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 993 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 480 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 269 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2009 | 162 | 0.020 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2009 | 98 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2023 | 0.020 |
Why?
|
| Neurons | 1 | 2016 | 1620 | 0.020 |
Why?
|
| Inpatients | 1 | 2010 | 369 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 889 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2010 | 486 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1255 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 2041 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 252 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 4116 | 0.010 |
Why?
|